US Patent 7326716 Treatment of inflammatory bowel disease
Patent 7326716 was granted and assigned to Allergan, Inc. on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Daniel W. Gil0
Danny T. Dinh0
David W. Old0
Karen M. Kedzie0
Wha Bin Im0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+249 characters)
Article
Patent abstract
The present invention provides a method of treating inflammatory bowel disease which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a piperidinyl prostaglandin E analog.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07326716 Treatment of inflammatory bowel disease US Patent 7326716 Treatment of inflammatory bowel disease
Infobox
Patent Number
073267160
Patent Number
73267160
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073267160
Date of Patent
February 5, 2008
0Patent Application Number
109994510
Date Filed
November 29, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07326716 Treatment of inflammatory bowel disease
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07326716
Date of patent
February 5, 2008
Patent application number
10999451
Date Filed
November 29, 2004
Patent primary examiner
Find more entities like US Patent 7326716 Treatment of inflammatory bowel disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
